Prescribing information available here

Adverse event reporting information can be found at the bottom of this page


The Bufomix (budesonide/formoterol) Easyhaler® range delivers effective, well-tolerated, and affordable therapy for asthma and COPD care.
The maintenance and reliever therapy indication in asthma for all ages from 12 years allows flexible tailoring of therapy for patients. Bufomix Easyhaler® is certified carbon neutral and produced by Orion Pharma in Finland.1

  

Flexible_Solution_800px.png

 

Bufomix Easyhaler Contraindications and Undesirable effects

ContraindicationsHypersensitivity to the active substances or lactose monohydrate (which contains small amounts of milk protein).

Undesirable effects:

Common (≥1/100 to < 1/10): Candida infections in the oropharynx, pneumonia (in COPD patients) headache, tremor, palpitations, mild irritation in the throat, coughing, dysphonia including hoarseness.

See SmPC for full list of adverse reactions 

 

Date of preparation: October 2024 / EASYH-2728(1)

 

References

  1. Budesonide-formoterol Easyhaler 80/4.5, 160/4.5, and 320/9 mcg. SmPC. Orion Pharma.